IMMUNOMEDICS INC

Q: Jun 30 2020

Q: Mar 31 2020

FY: Dec 31 2019

Q: Sep 30 2019

Q: Jun 30 2019

Q: Mar 31 2019

FY: Dec 31 2018

FY: Jun 30 2018

Q: Sep 30 2018

FY: Jun 30 2018

FY: Jun 30 2018

FY: Jun 30 2018

Q: Mar 31 2018

Q: Dec 31 2017

Q: Sep 30 2017

Q: Mar 31 2017

FY: Jun 30 2017

Q: Mar 31 2017

FY: Jun 30 2017

Q: Mar 31 2017

2.01,3.01,3.03,5.01,5.02,5.03,9.01

8.01,9.01

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Entry into a Material Definitive Agreement

Other Events

Results of Operations and Financial Condition

8.01,9.01

5.02,5.03,5.07,9.01

5.02,8.01,9.01

5.02,9.01

8.01,9.01

1.01,8.01,9.01

8.01,9.01

5.02

5.02,8.01,9.01

8.01,9.01

8.01,9.01

5.02,8.01,9.01

2.02,9.01

5.02,8.01,9.01

Certification of termination of registration of a class of securities (Section 12(g))

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Notice of Effectiveness

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Notification of removal from listing and/or registration on a national securities exchange

Post-effective amendment to a registration statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

No description available

Preliminary Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Required Information in Proxy Statement

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional proxy soliciting materials filed by a non-management party

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Additional Information for Proxy Statement/ Votes

Point72 Asset Management, L.P.

BlackRock Inc.

Fricker William

Delaney Brendan

Freedberg Jared

BALL BRYAN

Islam Khalid

Andrews Kurt J.

ITRI LORETTTA M

HUTT PETER BARTON

Azelby Robert

Canute Scott A

Malik Usama

Aghazadeh Behzad;Avoro Capital Advisors LLC

GILEAD SCIENCES INC

Duncan Barbara Gayle

BAUM CHARLES M

Avoro Capital Advisors LLC

IMMUNOMEDICS INC

IMMUNOMEDICS INC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

No description available

No description available

No description available

No description available

No description available

No description available

Letter from the SEC

No description available

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC